For payers, cost is the downside of continuing cardiovascular outcomes trials in current form

Autor:	Kenneth, Snow
Rok vydání:	2019
Předmět:	Clinical Trials as Topic Diabetes Mellitus Type 2 Cardiovascular Diseases United States Food and Drug Administration Humans Hypoglycemic Agents United States
Zdroj:	The American journal of managed care. 24(14 Spec)
ISSN:	1936-2692
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::7b2b149a26363ae1410fed2ee95dbe01 https://pubmed.ncbi.nlm.nih.gov/30620543 Zobrazit plný text záznamu